Specific allelic loss of p16 INK4A tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 419-424

  Hiroyasu, Makoto ^a   Ozeki, Munetaka ^a   Kohda, Haruyasu ^a   Echizenya, Michiko ^a   Tanaka, Tomoyuki ^a   Hiai, Hiroshi ^a   Toyokuni, Shinya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FREE RADICAL; NITRILOTRIACETATE IRON; PROTEIN P16; PROTEIN P53;

ALLELE; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REPLICATION; HISTOPATHOLOGY; KIDNEY CANCER; KIDNEY TUBULE CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

EID: 0036168274     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64860-2     Document Type: Article

References (37)

1. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
2. A cell cycle regulator potentially involved in genesis of many tumor types
3. Rates of p16 (MTS1) mutations in primary tumors with 9p loss
4. Role of the p16 tumor suppressor gene in cancer
5. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
6. Association of p19 (ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
7. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis
8. Loss of heterozygosity or intragenic mutation, which comes first?
9. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis
10. Occupational and environmental radiation and cancer
11. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis
12. Iron-induced carcinogenesis: The role of redox regulation
13. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats
14. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate
15. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate
16. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate
17. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats
18. Low incidence of point mutations in H-, K-, and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate
19. Intranuclear distribution of 8-hydroxy-2′-deoxyguanosine: An immunocytochemical study
20. INK4a in primary rat lung tumors
21. Structure of the rat p53 tumor suppressor gene
22. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas
23. Cloning and characterization of two processed p53 pseudogenes from the rat genome
24. Cloning sequence of a processed p53 pseudogene from rat: A potential source of false "mutations" in PCR fragments of tumor DNA
25. Mutation analysis in two newly identified rat p53 pseudogenes
26. Processed pseudogene from the von Hippel-Lindau disease gene is located on human chromosome 1
27. Development of high-grade renal cell carcinomas in rats independent of somatic mutations in the Tsc2 and VHL tumor suppressor genes
28. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma
29. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma
30. Co-deletion of p15 and p16 in primary malignant mesothelioma
31. The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma
32. Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: Relevance to peroxynitrite mutagenesis
33. Analysis of 8-hydroxyguanine in rat kidney genomic DNA after administration of a renal carcinogen, ferric nitrilotriacetate
34. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers
35. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck